Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up

Bayne, 2016, Treatment of the primary tumor in metastatic prostate cancer: current concepts and future perspectives, Eur Urol, 69, 775, 10.1016/j.eururo.2015.04.036 Gandaglia, 2017, Robot-assisted radical prostatectomy and extended pelvic lymph node dissection in patients with locally-advanced prostate cancer, Eur Urol, 71, 249, 10.1016/j.eururo.2016.05.008 Culp, 2014, Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor?. A SEER-based study, Eur Urol, 65, 1058, 10.1016/j.eururo.2013.11.012 Heidenreich, 2015, Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study, J Urol, 193, 832, 10.1016/j.juro.2014.09.089 Sooriakumaran, 2016, A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation, Eur Urol, 69, 788, 10.1016/j.eururo.2015.05.023 Gratzke, 2014, Role of radical prostatectomy in clinically non-organ-confined prostate cancer, Curr Urol Rep, 15, 455, 10.1007/s11934-014-0455-9 Kadmon, 1982, Treatment of a metastatic prostate derived tumor with surgery and chemotherapy, J Urol, 127, 1238, 10.1016/S0022-5347(17)54306-2 Gandaglia, 2016, Rationale for local treatment in the management of metastatic prostate cancer, Curr Opin Support Palliat Care, 10, 266, 10.1097/SPC.0000000000000218 Gandaglia, 2014, Survival benefit of definitive therapy in patients with clinically advanced prostate cancer: estimations of the number needed to treat based on competing-risks analysis, BJU Int, 114, E62, 10.1111/bju.12645 Ost, 2014, Prognostic factors influencing prostate cancer-specific survival in non-castrate patients with metastatic prostate cancer, Prostate, 74, 297, 10.1002/pros.22750 Halabi, 2016, Meta-analysis evaluating the impact of site of metastasis on overall survival in men with castration-resistant prostate cancer, J Clin Oncol, 34, 1652, 10.1200/JCO.2015.65.7270 Halabi, 2014, Updated prognostic model for predicting overall survival in first-line chemotherapy for patients with metastatic castration-resistant prostate cancer, J Clin Oncol, 32, 671, 10.1200/JCO.2013.52.3696 Gandaglia, 2015, Impact of the site of metastases on survival in patients with metastatic prostate cancer, Eur Urol, 68, 325, 10.1016/j.eururo.2014.07.020 Conde Moreno, 2014, Oligometastases in prostate cancer: restaging stage IV cancers and new radiotherapy options, Radiat Oncol, 9, 258, 10.1186/s13014-014-0258-7 Kim, 2009, Tumor self-seeding by circulating cancer cells, Cell, 139, 1315, 10.1016/j.cell.2009.11.025 Engel, 2010, Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer, Eur Urol, 57, 754, 10.1016/j.eururo.2009.12.034 Gandaglia, 2015, Comparative effectiveness of robot-assisted vs. open radical prostatectomy in intermediate- and high-risk patients, Eur Urol Suppl, 14, e621, 10.1016/S1569-9056(15)60614-5 Gandaglia, 2014, Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era, J Clin Oncol, 32, 1419, 10.1200/JCO.2013.53.5096